9
Jun 2026
Experimental two‑in‑one vaccine shows success in human LASSARAB trial
Researchers from Thomas Jefferson University and the University of Maryland School of Medicine have reported encouraging results from the first human clinical trial of LASSARAB, an experimental vaccine designed to protect against Lassa fever and rabies in a single formulation.